Cargando…

TREX1 as a Novel Immunotherapeutic Target

Mutations in the TREX1 3’ → 5’ exonuclease are associated with a spectrum of autoimmune disease phenotypes in humans and mice. Failure to degrade DNA activates the cGAS-STING DNA-sensing pathway signaling a type-I interferon (IFN) response that ultimately drives immune system activation. TREX1 and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemphill, Wayne O., Simpson, Sean R., Liu, Mingyong, Salsbury, Freddie R., Hollis, Thomas, Grayson, Jason M., Perrino, Fred W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047136/ https://www.ncbi.nlm.nih.gov/pubmed/33868310 http://dx.doi.org/10.3389/fimmu.2021.660184

Ejemplares similares

DNA binding induces active site conformational change in the human TREX2 3′-exonuclease
por: de Silva, Udesh, et al.
Publicado: (2009)

Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T‐follicular helper cells and germinal center B cells
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic TREX1 Missense Variants Affecting the Catalytic Core
por: Amico, Giulia, et al.
Publicado: (2022)

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma
por: Liu, Zhenjiang, et al.
Publicado: (2017)

A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients
por: Eugster, Anne, et al.
Publicado: (2022)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
por: Monticone, Giulia, et al.
Publicado: (2022)

Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients
por: Eugster, Anne, et al.
Publicado: (2022)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
por: Khan, Maliha, et al.
Publicado: (2018)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
por: Schneider, Helga, et al.
Publicado: (2014)

The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
por: Strickland, Lincoln N., et al.
Publicado: (2023)

Unraveling immunotherapeutic targets for endometriosis: a transcriptomic and single-cell analysis
por: Zhou, Cankun, et al.
Publicado: (2023)

Immunotherapeutic Potential of Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2014)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors
por: Tatari, Nazanin, et al.
Publicado: (2022)

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
por: Xue, Qianqian, et al.
Publicado: (2023)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis
por: Manils, Joan, et al.
Publicado: (2015)

Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer
por: Zecca, Alessandra, et al.
Publicado: (2022)

Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
por: Yun, Chae-Ok, et al.
Publicado: (2022)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Immunotherapeutic progress and application of bispecific antibody in cancer
por: Kang, Jingyue, et al.
Publicado: (2022)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Mitotic Phosphorylation of TREX1 C Terminus Disrupts TREX1 Regulation of the Oligosaccharyltransferase Complex
por: Kucej, Martin, et al.
Publicado: (2017)

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
por: Whelan, Jack T., et al.
Publicado: (2023)

Aly and THO are required for assembly of the human TREX complex and association of TREX components with the spliced mRNA
por: Chi, Binkai, et al.
Publicado: (2013)

The molecular mechanism of DNA damage recognition by MutS homologs and its consequences for cell death response
por: Salsbury, Freddie R., et al.
Publicado: (2006)

Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2022)

Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
por: Mercer, Derry K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ucjgt55l96fqd5ljhnol8om3hp